-
公开(公告)号:US20180345016A1
公开(公告)日:2018-12-06
申请号:US15994028
申请日:2018-05-31
Inventor: Peter Igoche Agada , John Jeka
Abstract: The present invention provides in part wearable devices for balance control. The wearable devices are capable of non-invasively monitoring and stimulating the wearer's vestibular system such that it produces postural responses. The wearable devices deliver low levels of electrical current to the vestibular system of a user to maintain balance. In one example, the wearable device is in the form of a pair of glasses.
-
公开(公告)号:US10136639B2
公开(公告)日:2018-11-27
申请号:US15034375
申请日:2014-11-05
Inventor: William Wuest , Kevin Patrick Minbiole
IPC: A01N25/08 , A01N33/12 , A01N43/40 , A61K31/132 , C07C211/63 , C07C323/25 , C07D213/22
Abstract: The present disclosure provides an antimicrobial composition including a polycationic amphiphile compound, and the method of making and the method of using such a compound or composition. The compound having the formula (I) or (II) R1, R2, R3, R4, R5, R6, R10, or R11 is H or a C1-12 alkyl unsubstituted or optionally substituted with a functional group such as —OH, —OR′, —NH2, —NHR′, —NR′2, —N—C(O)R′, —N—C(O)CR′═CR′, —SH, —SR′, —O—C(O)R′, —C(O)R′, —CF3, —OCF3, halogen, benzyl, o-vinylbenzyl, m-vinylbenzyl, p-vinylbenzyl, phenyl, allyl, and substituted allyl. R7, R8 or R9 is a C1-12 alkyl unsubstituted or optionally substituted with a functional group such as —OH, —OR′, —NH2, —NHR′, —NR′2, —SH, —SR′, —O—C(O)R′, —C(O)R′, —CF3, and —OCF3. R′ is H or a C1-4 alkyl. X or Y is a halogen, m and n are integers in the range from 1 to 25.
-
公开(公告)号:US20180330208A1
公开(公告)日:2018-11-15
申请号:US15914317
申请日:2018-03-07
Inventor: Chang-Hee Won
CPC classification number: G06K9/78 , A61B5/0053 , A61B5/0077 , A61B5/442 , A61B5/444 , A61B5/7267 , A61B2562/0233 , G01L1/24 , G01L1/247 , G02B6/0013 , G02B6/0045 , G02B6/12002 , G06F3/016 , G06F3/0414 , H04N7/18
Abstract: A tactile sensor, computer readable medium, methods of using and manufacturing the tactile sensor, and methods and apparatuses for processing the information generated by the tactile sensor. The tactile sensor includes a planar optical waveguide comprised of a flexible and transparent layer, a light configured to direct light into the optical waveguide; a light sensor or an imager facing the optical waveguide and configured to generate signals from light scattered out of the optical waveguide; and a controller which may be configured to generate an image of the object and characteristics of the object. The waveguide may be configured so that some of the light directed into the optical waveguide is scattered out of the waveguide if the waveguide is deformed by being pressed against the object. A finite element and a neural network are used to estimate mechanical characteristics of the objects.
-
公开(公告)号:US20180296649A1
公开(公告)日:2018-10-18
申请号:US15578372
申请日:2016-06-01
Inventor: Kamel Khalili , Wenhui Hu , Yonggang Zhang
Abstract: Compositions for specifically cleaving target sequences in retroviruses include nucleic acids encoding a Clustered Regularly Interspace Short Palindromic Repeat (CRISPR) associated endonuclease and a guide RNA sequence complementary to one or more target nucleic acid sequences in a retrovirus genome.
-
公开(公告)号:US10054583B2
公开(公告)日:2018-08-21
申请号:US14435000
申请日:2013-10-09
Inventor: Oscar M. Perez-Leal , Salim Merali , Carlos A. Barrero
IPC: G01N33/50 , C12Q1/68 , C12Q1/6883 , A61K31/05 , A61K31/136 , A61K31/225 , A61K31/353 , C07K14/47 , C12Q1/6897
CPC classification number: G01N33/5023 , A61K31/05 , A61K31/136 , A61K31/225 , A61K31/353 , C07K14/4701 , C12Q1/6883 , C12Q1/6897 , C12Q2600/156
Abstract: Compositions include nucleic acid sequences encoding the C-terminal fragment of fragment (Seg3) of Nuclear factor-erythroid 2 related factor 2 (Nrf2). These compositions provide a target for identification of novel therapeutics having the ability to modulate the translation of Nrf2. Methods of treating subjects are also provided.
-
146.
公开(公告)号:US20180214399A1
公开(公告)日:2018-08-02
申请号:US15903514
申请日:2018-02-23
Inventor: Ira C. Spector , Mark A. Feitelson , Alla Arzumanyan
CPC classification number: A61K31/19 , A61K9/0014 , A61K9/0048 , A61K9/4891 , A61K45/06 , A61K2300/00 , A61P17/00 , A61P27/02 , A61P35/00 , A61P37/08
Abstract: The invention relates to compositions and methods that include short chain fatty acids (SCFAs), related therapeutic compounds, and other compounds, including combinations thereof, for the treatment or prevention of diseases or disorders.
-
公开(公告)号:US09981020B2
公开(公告)日:2018-05-29
申请号:US15148261
申请日:2016-05-06
Inventor: Kamel Khalili , Wenhui Hu
IPC: A61K48/00 , A61K38/46 , A61K9/00 , A61K35/12 , A61K45/06 , C12N7/00 , C12N9/22 , C12N15/11 , A61K39/21 , C12N15/55 , C12N15/79 , C12N15/85 , C12N15/86
CPC classification number: A61K38/465 , A61K9/0034 , A61K35/12 , A61K45/06 , A61K48/00 , A61K48/005 , C12N7/00 , C12N9/22 , C12N15/111 , C12N2310/20 , C12N2320/30 , C12N2740/16063 , C12Y301/21
Abstract: A method of inactivating a proviral DNA integrated into the genome of a host cell latently infected with a retrovirus by treating the host cell with a composition comprising a Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated endonuclease, and two or more different guide RNAs (gRNAs), wherein each of the at least two gRNAs is complementary to a different target nucleic acid sequence in a long terminal repeat (LTR) in the proviral DNA, and inactivating the proviral DNA. A composition for use in inactivating a proviral DNA integrated into the genome of a host cell latently infected with a retrovirus including isolated nucleic acid sequences comprising a CRISPR-associated endonuclease and a guide RNA, wherein the guide RNA is complementary to a target sequence in a human immunodeficiency virus.
-
公开(公告)号:US20180105867A1
公开(公告)日:2018-04-19
申请号:US15787319
申请日:2017-10-18
Applicant: Drexel University , The Wistar Institute of Anatomy and Biology , Temple University - of the Commonwealth System of Higher Education
Inventor: Ming Xiao , Harold C. Riethman , Wenhui Hu , Jennifer McCaffrey
CPC classification number: C12Q1/6806 , C12Y301/00 , G01N1/30 , G01N21/6428 , G01N2021/6439 , C12Q2521/301
Abstract: Provided herein are methods of detecting a target nucleic acid sequence. In one embodiment, the method includes contacting genomic DNA with a guide RNA having a portion complementary to the target sequence in the genomic DNA and with Cas9 nickase to produce a single-strand break in the genomic DNA at a specific location adjacent to the target sequence. The method further includes contacting the nicked DNA with a polymerase and fluorescently labeled nucleotide. The fluorescently labeled nucleotide is incorporated into the nicked DNA at the specific location and the target nucleic acid sequence is detected via fluorescent label.
-
公开(公告)号:US09903871B2
公开(公告)日:2018-02-27
申请号:US14800162
申请日:2015-07-15
Inventor: Frank N. Chang , George P. Tuszynski
IPC: G01N33/574 , G01N33/563 , G01N33/577 , C07K16/40
CPC classification number: G01N33/57488 , C07K16/40 , C07K2317/21 , C07K2317/24 , C07K2317/34 , C07K2317/76 , G01N2333/902 , G01N2333/908 , G01N2800/52
Abstract: An embodiment of the invention relates to the use of stabilized cancer peptide fragments derived from “redoxin proteins” selected from the group consisting of thioredoxin; peroxiredoxin-1, 2 and 3; glutaredoxin-3; glutathione peroxidase-4; and nucleoredoxins for the diagnosis of cancers, particularly pancreatic cancer. A method for the detection of cancer, severity of cancer, and/or effectiveness of a therapeutic regimen comprises detecting and/or measuring the amount of redoxin peptide fragments present in the biological sample of a subject.
-
150.
公开(公告)号:US20180008641A1
公开(公告)日:2018-01-11
申请号:US15527767
申请日:2015-11-18
Inventor: Raj Kishore , Venkata Naga Srikanth Garikipati
CPC classification number: A61K35/28 , A61K31/7105 , A61K38/2066 , A61K48/00 , C12P19/34 , A61K2300/00
Abstract: The present invention relates to compositions and methods useful for treating ischemic injury. In one embodiment, the present invention uses an inhibitor of miR-375 in a cell to enhance its survival.
-
-
-
-
-
-
-
-
-